Articles From: RealPage Announces Preliminary Second Quarter 2014 Financial Results to Reckitt Benckiser leads U.K.'s FTSE 100 higher


2014/7/17
RealPage, Inc. (NASDAQ: RP ), a leading provider of on-demand property management solutions, today announced preliminary Non-GAAP total revenue and Adjusted EBITDA results for the second quarter ended June 30, 2014.
Sign-up for RealPage Announces Preliminary Second Quarter 2014 Financial Results investment picks
2014/8/4
RealPage, Inc. (NASDAQ: RP ), a leading provider of on demand software and software-enabled services to the rental housing industry, today announced financial results for its second quarter ended June 30, 2014.
Sign-up for RealPage Reports Second Quarter 2014 Financial Results investment picks
2014/7/18
NEW YORK (MarketWatch) -- Shares of RealPage (RP) tumbled 25% to a near five-month low after the rental-property management software company cut its second-quarter sales outlook, citing disappointing revenue from services related to leasing activity.
Sign-up for RealPage shares tumble after revenue outlook slashed investment picks
2014/8/6
SAN JOSE, Calif.
Sign-up for Realtor.com® Data Reveals 10 Metro Markets With Bright Q3 Sales Indicators investment picks
2014/9/17
SAN JOSE, Calif.
Sign-up for Realtor.com® Enhances Consumer Experience by Optimizing Real Estate App for iOS 8 investment picks
2014/7/17
SAN JOSE, Calif.
Sign-up for Realtor.com® Finds 67 Percent of Consumers Plan Home Improvements in the Next Six Months investment picks
2014/7/1
SAN JOSE, Calif.
Sign-up for Realtor.com® Reveals Most Popular Cities for Renters on the Go investment picks
2014/9/3
Mr. Malino to step down as President & Chief Operating Officer on October 1, 2014 ESCONDIDO, Calif.
Sign-up for Realty Income Announces Sumit Roy To Succeed Gary M. Malino As Chief Operating Officer investment picks
To Ring The Closing Bell® ESCONDIDO, Calif.
Sign-up for Realty Income Celebrates 20 Years On The NYSE investment picks
2014/9/9
ESCONDIDO, Calif.
Sign-up for Realty Income Declares Preferred Stock Monthly Dividends investment picks
2014/9/16
ESCONDIDO, Calif.
Sign-up for Realty Income Prices $250 Million Of 4.125% Senior Unsecured Notes Due 2026 investment picks
2014/9/16
ESCONDIDO, Calif.
Sign-up for Realty Income To Redeem All Outstanding Shares Of 6.75% Monthly Income Class E Preferred Stock investment picks
2014/7/11
http://media.marketwire.com/attachments/201301/119522_realtytraclogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1130444&ProfileId=051205&sourceType=1 IRVINE, CA --
Sign-up for RealtyTrac Foreclosure Data Integrated Into RE/MAX Search investment picks
2009/04/06
Your step-by-step guide to restoring your asset allocation.
Sign-up for Rebalancing Made Simple investment picks
2011/10/20
A step-by-step guide to restoring your asset allocation.
Sign-up for Rebalancing Made Simple investment picks
MetLife, Inc. (NYSE: MET) announced today that Rebecca Tadikonda will join the company as chief enterprise strategy officer effective July 21, 2014.
Sign-up for Rebecca Tadikonda to Join MetLife as Chief Enterprise Strategy Officer investment picks
Whole Foods Market (NASDAQ: WFM), the world’s leading natural and organic foods supermarket, is launching Wine Club by Whole Foods Market on Oct.
Sign-up for Receive Exceptional Wines Delivered to Your Front Door with New Wine Club by Whole Foods Market® investment picks
American Vanguard Corporation (NYSE:AVD) today announced that lower than normal purchasing of corn inputs and reduced production levels at the Company’s manufacturing facilities will affect second quarter 2014 financial performance.
Sign-up for Recent Agricultural Purchasing Patterns and Lower Factory Utilization Rates Will Affect American Vanguard’s Second Quarter 2014 Financial Performance investment picks
2014/9/3
Utility Participates in Several Community Events throughout the Month to Share Safety and Preparedness Information and Demonstrate Gas and Electric Hazards with Customers SAN FRANCISCO , Sept.
Sign-up for Recent Earthquake in Napa County Reminder to PG&E Customers to "Be Prepared" During National Preparedness Month investment picks
Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today highlighted three recent review articles examining the current clinical use of levosimendan and its potential to address a wide range of critical care conditions.
Sign-up for Recent Scientific Publications Highlight Potential Benefits of Levosimendan in Cardiac Surgery and Additional Critical Care Conditions investment picks
SAN DIEGO, July 29, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT) , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced the appointment of Mary Szela and Richard Heyman to the board of directors of Receptos.
Sign-up for Receptos Announces Appointment of Mary Szela and Richard Heyman, Ph.D. to Board of Directors investment picks
SAN DIEGO, June 24, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT) , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, announced today closing of the previously announced underwritten public offering of 4,433,000 shares of its common stock at a price to the public of $40.25 per share.
Sign-up for Receptos Announces Closing of Underwritten Public Offering of Common Stock investment picks
Detailed Results of Positive Phase 2 Trial of RPC1063 in Relapsing Multiple Sclerosis to be Presented at Late Breaker Session on September 13, 2014 SAN DIEGO, Sept.
Sign-up for Receptos Announces Oral Podium Presentation at MS Boston 2014 investment picks
SAN DIEGO, June 18, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT) , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, announced today the pricing of an underwritten public offering of 4,433,000 shares of its common stock at a price to the public of $40.25 per share.
Sign-up for Receptos Announces Pricing of Underwritten Public Offering of Common Stock investment picks
SAN DIEGO, June 17, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT) , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, announced today that it intends to offer shares of its common stock in an underwritten public offering.
Sign-up for Receptos Announces Proposed Underwritten Public Offering of Common Stock investment picks
Completes enrollment of Phase 2 trial of RPC1063 in Ulcerative Colitis; data expected in fourth quarter of 2014 SAN DIEGO, Aug.
Sign-up for Receptos Reports Second Quarter 2014 Financial Results investment picks
SAN DIEGO, Aug.
Sign-up for Receptos to Present at Wedbush PacGrow Life Sciences Conference investment picks
2014/7/28
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Shares of Reckitt Benckiser Group PLC led the U.K.'s FTSE 100 index to a strong start to the week, after the consumer-product company said it plans to spin off a division.
Sign-up for Reckitt Benckiser leads U.K.'s FTSE 100 higher investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: RealPage Announces Preliminary Second Quarter 2014 Financial Results to Reckitt Benckiser leads U.K.'s FTSE 100 higher
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices